arsenal
Exclusive: Cancer drugmaker Tesaro attracts takeover interest – sources
February 8, 2017 by publisher · Leave a Comment
The takeover interest in Tesaro underscores the pharmaceutical industry's strong appetite for the acquisition of biotechnology companies with promising medicines under development in lucrative sectors such as cancer treatment. Tesaro is not actively exploring a sale, the people said this week, noting that there is a significant gap over the company's valuation between Tesaro and potential acquirers.
Read the original:
Exclusive: Cancer drugmaker Tesaro attracts takeover interest – sources
arsenal
Microsoft offers patent troll defense for cloud customers
February 8, 2017 by elegant · Leave a Comment
Companies new to the cloud are vulnerable to non-practicing entities, which do not make any products themselves but use their arsenal of broad technology patents to sue other firms in order to extract royalties or a cash settlement. The new offering could appeal to companies new to the cloud arena, needing a service such as Microsoft's Azure to store their data or…
Original post:
Microsoft offers patent troll defense for cloud customers